# US 2009/0221806 A1 · Method for Producing a Beta-1,3-Glucan With Improved Characteristics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0221806 A1
- Document ID: US20090221806A1
- Status: Published application
- Kind: A1
- Application number: 10/544,820
- Filed: 2004-03-04
- Published: 2009-09-03
- Earliest claimed: 2003-03-04
- Inventors: Werner Frohnwieser; Michael Volland; Evi Wittmann; Fabienne Skorupinsui; Jean Jacques Lebehot; Yves Lemoigne; Thomas Lötzbeyer
- Web page: https://patentgrep.com/patent/US20090221806A1

## CPC

- C12P 19/04: Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
- C08B 37/0024: {beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof}
- C12P 19/14: produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase}
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C08B: POLYSACCHARIDES; DERIVATIVES THEREOF (polysaccharides containing less than six saccharide radicals attached to each other by glycosidic linkages C07H; fermentation or enzyme-using processes C12P19/00; sugar industry C13; production of cellulose D21)

## Abstract

In this process for preparing a β-1,3-glucan, the glucan-containing matrix is treated with a protein having β(1,3)-glucanase activity, wherein the concentration of the glucanase amounts from 0.001 to 3.0% by weight. The glucan-containing matrix can be a fermentation broth, a culture medium or a suspension, where appropriate containing unsolved solids, cell constituents and/or cell fragments, or else a mycelium, a hydrocolloid or a powder preparation having a solvent proportion of from 20 to 99.9% by weight. The duration of the enzymatic treatment should be between 15 minutes and 24 hours and the treatment should be carried out continuously. The invention also envisages the glucan-containing matrix being filtered or centrifuged, after it has been treated enzymatically, and the glucan finally being separated off. A β-1,3-glucan which has been prepared in this way and which exhibits, for example, improved solubility in cold water, reduced proportions of insoluble constituents, an increased viscosity or improved filterability, is also claimed. A solid formulation and the use of these glucans for cosmetic applications, foodstuffs or oil production are also coclaimed.

## Claims

### Claim at position 1

1-22. (canceled)

### Claim 23

A process for preparing a β-1,3-glucan, comprising stirring a glucan-containing matrix at temperatures of between 15 and 60° C. and at a pH of between 4.0 and 10.0, in water as solvent and then treating with a protein possessing β(1,3)-glucanase activity.

### Claim 24 (depends on 23)

The process as claimed in claim 23, wherein the β-1,3-glucan has β(1,6)-glucose side chains.

### Claim 25 (depends on 23)

The process as claimed in claim 23, wherein the protein is β(1,3)-glucanase.

### Claim 26 (depends on 23)

The process as claimed in claim 23, wherein the protein has β(1,4)-glucanase activity.

### Claim 27 (depends on 23)

The process as claimed in claim 23, wherein the concentration of the protein having β(1,3)-glucanase activity is from 0.001 to 3.0% by weight based on the reaction mixture.

### Claim 28 (depends on 23)

The process as claimed in claim 23, wherein the process is carried out at temperatures of between 20 and 40° C.

### Claim 29 (depends on 23)

The process as claimed in claim 23, carried out at room temperature.

### Claim 30 (depends on 23)

The process as claimed in claim 23, wherein the glucan-containing matrix is a fermentation broth, a culture medium, a suspension or a mycelium, a hydrocolloid or a powder preparation containing a solvent proportion of from 20 to 99.9% by weight and, in particular, of from 50 to 99% by weight based on the solids content.

### Claim 31 (depends on 23)

The process as claimed in claim 23, wherein the fermentation broth or the culture medium contains unsolved solids, cell constituents and/or cell fragments.

### Claim 32 (depends on 23)

The process as claimed in claim 23, wherein the mycelium, the hydrocolloid or the powder preparation is employed as an aqueous solution.

### Claim 33 (depends on 23)

The process as claimed in claim 23, wherein the matrix contains water as solvent.

### Claim 34 (depends on 23)

The process as claimed in claim 23, wherein the pH of the matrices is between 5.0 and 7.0.

### Claim 35 (depends on 23)

The process as claimed in claim 23, wherein the duration of the enzymatic treatment is from 15 minutes to 24 hours and, in particular, from 1 to 6 hours.

### Claim 36 (depends on 23)

The process as claimed in claim 23, wherein it is carried out continuously.

### Claim 37 (depends on 23)

The process as claimed in claim 23, wherein after the glucan-containing matrix has been treated enzymatically, it is subjected to a heat treatment at temperatures of between 70 and 150° C.

### Claim 38 (depends on 37)

The process as claimed in claim 37, wherein the heat treatment is carried out for 1 to 60 minutes.

### Claim 39 (depends on 23)

The process as claimed in claim 23, wherein the glucan-containing matrices are finally subjected to a filtration and/or centrifugation.

### Claim 40 (depends on 23)

The process as claimed in claim 23, wherein the glucan is separated off.

### Claim 41 (depends on 40)

The process as claimed in claim 40, wherein separation is by evaporation freeze-drying or precipitation.

### Claim 42 (depends on 23)

A β-1,3-glucan obtained by the process of claim 23.

### Claim 43 (depends on 42)

A β-1,3-glucan as claimed in claim 42, wherein that exhibits improved solubility in cold water and/or reduced proportions of insoluble constituents and/or an increased viscosity and/or reduced turbidity in aqueous solutions and/or improved filterability.

### Claim 44

A solid formulation comprising at least from 90 to 99.9% by weight of an untreated β-1,3-glucan, from 0.005 to 0.1% by weight of a protein having β(1,3)-glucanase activity and from 0 to 10% by weight of at least one further constituent, such as fillers, inert diluents or a mycelium.

### Claim 45 (depends on 42)

A cosmetic comprising the β-1,3-glucan of claim 42.

### Claim 46 (depends on 42)

A food product comprising the β-1,3-glucan of claim 42
